Endeavor BioMedicines

Endeavor BioMedicines is pleased to welcome Lisa Lancaster, M.D., as Chief Medical Officer. A renowned pulmonologist and clinical researcher focused on interstitial lung disease (ILD), Dr. Lancaster will play a key role in guiding our clinical development programs.   Learn more: https://bit.ly/4iPQGLc

🌟 Welcoming New Talent at Endeavor BioMedicines! 🌟    We’re committed to developing transformative medicines that may restore hope for patients with intractable diseases, and we're excited to introduce some of our newest team members to help us with that cause.  Please join us in extending a warm welcome to Rebekah Blankenship, Amanda Echevarria, CCRA, Rachael Hildebrandt, MA PHR, Jason Jones, Enoch Kariuki, PharmD, Chris Krueger, April Lee, Corey Pecoraro, CPA, Vishaal Turakhia, and Karen W. ! Your passion and expertise will play a crucial role in our mission. Here's to a future of excellence and collaboration at #TeamEndeavor!      #CompanyGrowth #NewHires #IPF #oncology

#TeamEndeavor has worked together this year to create potential new therapeutic possibilities for people with life-threatening diseases. We are proud of each person on our team and thankful for their contributions. As we go into a season of #gratitude, we asked our team what they are grateful for; take a listen to what they said.     We hope you have a relaxing and fulfilling #Thanksgiving week! 

#NEWS: Today we announced that the first patient has been dosed in our Phase 2b WHISTLE-PF #clinicaltrial evaluating our lead #investigational medicine, ENV-101, in patients with idiopathic pulmonary fibrosis (IPF).  Thank you to our dedicated employees as well as the trial participants for their crucial support. Learn more here: https://bit.ly/3UZ19Ku #innovation #science #biotechnews #pharmanews

Caring for a loved one with idiopathic pulmonary fibrosis (IPF) can be both rewarding and challenging. This National Family Caregivers Month, we recognize the incredible caregivers who provide essential care to people with #IPF. If you are a caregiver for someone with this disease, thank you for all you do. The Pulmonary Fibrosis Foundation has some useful resources here: https://bit.ly/3YtTdlx #pulmonaryfibrosis #NationalFamilyCaregiversMonth #NFCMonth #familycaregivers

We hope you had a happy #Halloween 🎃! We celebrated with a day filled with creativity, fun, and #innovation.

Endeavor was honored to participate at #ICLAF2024, the International Colloquium on Lung and Airway Fibrosis, in Athens, Greece! This was a fantastic opportunity to connect with leading #researchers and discuss new advancements in #pulmonaryfibrosis.     #IPF #innovation 

As part of our #PFMonth education activities, we had the honor of hosting PF Warriors’ Teresa Barnes, Chief Executive Warrior, Dolly Kervitsky, President, and MaryLuz Fuentes, MD, Director, Spanish Language Program, who shared their experience with #pulmonaryfibrosis during a company-wide event. PF Warriors' mission to help people facing these life-altering progressive lung conditions to live their best possible lives after diagnosis inspires us in our own mission – to disrupt disease and restore hope. Learn more about PF Warriors’ impactful work: https://bit.ly/3ZjJPCQ

This #PFMonth and always, Endeavor BioMedicines is inspired by the individuals who are personally impacted by idiopathic pulmonary fibrosis (#IPF). We are committed to developing therapies that precisely target the root cause of this challenging disease and have the potential to deliver transformational clinical benefits and restore hope for those it affects. Learn more about our science here: https://bit.ly/3MGkZ8Y #PFAM #PFMonth #ThoughtLeadership #BioMedicines 

At Endeavor BioMedicines, we are developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases. Our team is working to restore hope for patients, including progressing our investigational candidate ENV-101 for the treatment of idiopathic pulmonary fibrosis. (IPF). #EveryBreathEveryStory #PFAM #PFMonth #PFMonth24